Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
$398.47
+0.9%
$376.23
$205.10
$415.00
$19.08B0.9318,141 shs202,235 shs
Yunhong CTI Ltd. stock logo
CTIB
Yunhong CTI
$1.93
$0.33
$2.40
$48.24M0.9536,835 shs242,300 shs
Veru Inc. stock logo
VERU
Veru
$1.63
-0.6%
$0.93
$0.36
$1.92
$238.60M-0.474.18 million shs2.92 million shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$365.02
-0.9%
$377.90
$310.42
$415.73
$26.59B1.05447,014 shs451,107 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
+0.77%-0.59%+0.61%+24.16%+87.00%
Yunhong CTI Ltd. stock logo
CTIB
Yunhong CTI
0.00%0.00%0.00%0.00%+71.43%
Veru Inc. stock logo
VERU
Veru
-0.61%+28.35%+96.62%+226.00%+28.35%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
-0.99%+1.27%-5.72%-4.20%-0.93%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
4.0675 of 5 stars
1.35.03.32.41.92.51.9
Yunhong CTI Ltd. stock logo
CTIB
Yunhong CTI
N/AN/AN/AN/AN/AN/AN/AN/A
Veru Inc. stock logo
VERU
Veru
1.2798 of 5 stars
3.41.00.00.02.91.70.0
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.8477 of 5 stars
2.45.01.73.23.32.53.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
2.50
Moderate Buy$416.004.40% Upside
Yunhong CTI Ltd. stock logo
CTIB
Yunhong CTI
N/AN/AN/AN/A
Veru Inc. stock logo
VERU
Veru
2.75
Moderate Buy$3.33104.50% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.80
Moderate Buy$435.2019.23% Upside

Current Analyst Ratings

Latest VERU, CTIB, CSL, and WST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/26/2024
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$412.00 ➝ $430.00
4/26/2024
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$435.00 ➝ $465.00
4/18/2024
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$405.00 ➝ $412.00
4/15/2024
Veru Inc. stock logo
VERU
Veru
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$7.00 ➝ $5.00
4/9/2024
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$400.00 ➝ $435.00
4/3/2024
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$455.00
4/1/2024
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$375.00 ➝ $440.00
3/28/2024
Veru Inc. stock logo
VERU
Veru
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$3.00
3/20/2024
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$355.00 ➝ $405.00
3/19/2024
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$365.00 ➝ $400.00
2/16/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$400.00 ➝ $375.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
$4.59B4.16$20.49 per share19.45$59.72 per share6.67
Yunhong CTI Ltd. stock logo
CTIB
Yunhong CTI
$18.05M0.00N/AN/A$0.06 per share0.00
Veru Inc. stock logo
VERU
Veru
$16.30M14.64N/AN/A$0.22 per share7.41
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.95B9.01$10.08 per share36.20$36.80 per share9.92

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
$765.80M$17.2523.1018.511.3517.13%30.41%12.99%7/24/2024 (Estimated)
Yunhong CTI Ltd. stock logo
CTIB
Yunhong CTI
-$1.47M-$0.12N/AN/AN/A-4.72%-32.60%-5.02%N/A
Veru Inc. stock logo
VERU
Veru
-$93.15M-$0.75N/AN/AN/A-405.04%-257.92%-107.27%5/8/2024 (Confirmed)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$593.40M$7.5848.1639.986.4919.42%20.57%15.47%7/25/2024 (Estimated)

Latest VERU, CTIB, CSL, and WST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
Veru Inc. stock logo
VERU
Veru
-$0.06N/A+$0.06N/AN/AN/A  
4/25/2024Q1 2024
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
$2.74$3.72+$0.98$3.47$993.06 million$1.10 billion    
4/25/2024Q1 2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.29$1.56+$0.27$1.57$670.62 million$695.40 million    
4/1/2024Q1 2024
Veru Inc. stock logo
VERU
Veru
N/A-$0.09-$0.09-$0.10N/A$2.14 million
2/15/202412/31/2023
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.78$1.83+$0.05$1.83$740.43 million$732.00 million      
2/6/2024Q4 2023
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
$3.47$4.17+$0.70$4.14$1.09 billion$1.13 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
$3.400.85%+16.00%19.71%47 Years
Yunhong CTI Ltd. stock logo
CTIB
Yunhong CTI
N/AN/AN/AN/AN/A
Veru Inc. stock logo
VERU
Veru
N/AN/AN/AN/AN/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.800.22%+5.81%10.55%1 Years

Latest VERU, CTIB, CSL, and WST Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/25/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Quarterly$0.200.22%7/31/20247/31/20248/7/2024
4/30/2024
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
quarterly$0.850.9%5/17/20245/20/20246/3/2024
2/20/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Quarterly$0.200.23%4/23/20244/24/20245/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
0.66
2.95
2.57
Yunhong CTI Ltd. stock logo
CTIB
Yunhong CTI
N/A
1.29
0.41
Veru Inc. stock logo
VERU
Veru
N/A
3.21
2.79
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.03
2.61
1.95

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
89.52%
Yunhong CTI Ltd. stock logo
CTIB
Yunhong CTI
1.89%
Veru Inc. stock logo
VERU
Veru
47.16%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
1.50%
Yunhong CTI Ltd. stock logo
CTIB
Yunhong CTI
36.38%
Veru Inc. stock logo
VERU
Veru
14.20%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.53%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
11,00047.88 million47.16 millionOptionable
Yunhong CTI Ltd. stock logo
CTIB
Yunhong CTI
5820.10 million12.79 millionNot Optionable
Veru Inc. stock logo
VERU
Veru
189146.38 million125.60 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,60072.84 million72.46 millionOptionable

VERU, CTIB, CSL, and WST Headlines

SourceHeadline
TCG Advisory Services LLC Buys Shares of 2,225 West Pharmaceutical Services, Inc. (NYSE:WST)TCG Advisory Services LLC Buys Shares of 2,225 West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - May 4 at 3:34 PM
Truist Financial Corp Cuts Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)Truist Financial Corp Cuts Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - May 2 at 5:40 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Rating of "Moderate Buy" from BrokeragesWest Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Rating of "Moderate Buy" from Brokerages
americanbankingnews.com - May 1 at 3:12 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2024 Earnings Call TranscriptWest Pharmaceutical Services, Inc. (NYSE:WST) Q1 2024 Earnings Call Transcript
finance.yahoo.com - April 30 at 9:32 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Russell Investments Group Ltd.West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Russell Investments Group Ltd.
marketbeat.com - April 30 at 7:20 AM
West to Participate in Upcoming Investor ConferenceWest to Participate in Upcoming Investor Conference
prnewswire.com - April 30 at 6:00 AM
West Pharmaceutical Services Posts Q1 2024 Financial Results, Updates Full-Year GuidanceWest Pharmaceutical Services Posts Q1 2024 Financial Results, Updates Full-Year Guidance
msn.com - April 29 at 8:30 AM
William Blair Research Analysts Lift Earnings Estimates for West Pharmaceutical Services, Inc. (NYSE:WST)William Blair Research Analysts Lift Earnings Estimates for West Pharmaceutical Services, Inc. (NYSE:WST)
americanbankingnews.com - April 29 at 2:28 AM
Paradiem LLC Has $3.49 Million Stake in West Pharmaceutical Services, Inc. (NYSE:WST)Paradiem LLC Has $3.49 Million Stake in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 28 at 1:50 PM
West Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsWest Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
finance.yahoo.com - April 28 at 12:07 PM
West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call TranscriptWest Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript
seekingalpha.com - April 27 at 4:03 PM
Bank Julius Baer & Co. Ltd Zurich Purchases Shares of 8,207 West Pharmaceutical Services, Inc. (NYSE:WST)Bank Julius Baer & Co. Ltd Zurich Purchases Shares of 8,207 West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 27 at 8:31 AM
Stevens Capital Management LP Purchases New Stake in West Pharmaceutical Services, Inc. (NYSE:WST)Stevens Capital Management LP Purchases New Stake in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 26 at 5:57 PM
West Pharmaceutical Services: Strong Q1 Performance and Upbeat FY24 Outlook Bolster Buy RatingWest Pharmaceutical Services: Strong Q1 Performance and Upbeat FY24 Outlook Bolster Buy Rating
markets.businessinsider.com - April 26 at 2:59 PM
West Pharmaceutical Services (NYSE:WST) Releases Quarterly  Earnings Results, Beats Expectations By $0.27 EPSWest Pharmaceutical Services (NYSE:WST) Releases Quarterly Earnings Results, Beats Expectations By $0.27 EPS
marketbeat.com - April 26 at 11:48 AM
West Pharmaceutical Services First Quarter 2024 Earnings: Beats ExpectationsWest Pharmaceutical Services First Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - April 26 at 9:58 AM
West Pharmaceutical Services, Inc. Declares Quarterly Dividend of $0.20 (NYSE:WST)West Pharmaceutical Services, Inc. Declares Quarterly Dividend of $0.20 (NYSE:WST)
marketbeat.com - April 26 at 8:00 AM
West Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...West Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
finance.yahoo.com - April 26 at 4:58 AM
Beyond The Earnings: What The Latest SEC 10-Q Filing Reveals About West Pharmaceutical Services, Inc. (WST) FutureBeyond The Earnings: What The Latest SEC 10-Q Filing Reveals About West Pharmaceutical Services, Inc. (WST) Future
americanbankingnews.com - April 26 at 4:06 AM
West Pharmaceutical Services, Inc. 2024 Q1 - Results - Earnings Call PresentationWest Pharmaceutical Services, Inc. 2024 Q1 - Results - Earnings Call Presentation
seekingalpha.com - April 25 at 5:43 PM
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales WeakWest Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
zacks.com - April 25 at 11:35 AM
West Pharmaceutical Services, Inc.: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 DividendWest Pharmaceutical Services, Inc.: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
finanznachrichten.de - April 25 at 8:55 AM
West Pharmaceutical: Q1 Earnings SnapshotWest Pharmaceutical: Q1 Earnings Snapshot
timesunion.com - April 25 at 8:55 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Illinois Municipal Retirement FundWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Illinois Municipal Retirement Fund
marketbeat.com - April 25 at 8:30 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Carlisle Companies logo

Carlisle Companies

NYSE:CSL
Carlisle Companies Incorporated operates as a manufacturer and supplier of building envelope products and solutions in the United States, Europe, North America, Asia and the Middle East, Africa, and internationally. It operates through two segments: Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company produces single-ply roofing products, and warranted roof systems and accessories, including ethylene propylene diene monomer, thermoplastic polyolefin and polyvinyl chloride membrane, polyiso insulation, and engineered metal roofing and wall panel systems for commercial and residential buildings. It also offers building envelope solutions, including high-performance waterproofing and moisture protection products, protective roofing underlayments, fully integrated liquid and sheet applied air/vapor barriers, sealants/primers and flashing systems, roof coatings and mastics, spray polyurethane foam and coating systems, block-molded expanded polystyrene insulation, and engineered products for HVAC applications. It sells its products under the Carlisle SynTec, Versico, WeatherBond, Hunter Panels, Resitrix, and Hertalan brands. Carlisle Companies Incorporated was founded in 1917 and is headquartered in Scottsdale, Arizona.
Yunhong CTI logo

Yunhong CTI

NASDAQ:CTIB
Yunhong CTI Ltd. develops, produces, distributes, and sells consumer products in the United States and internationally. It offers novelty products, including foil balloons; latex balloons under the Partyloons name; and toy balloon products, which include punch balls, water bombs, and balloons twisted into shapes, as well as other inflatable toy items. The company also offesrs packaging films and custom film products for food, and other commercial and packaging applications; and container products, as well as assembles and sells Candy Blossom product line. It primarily serves various retail outlets, including general merchandise stores, discount and drugstore chains, grocery chains, card and gift shops, party goods stores, and florists and balloon decorators. The company sells its products directly, as well as through a network of distributors and wholesalers, retail chains, and independent sales representatives. The company was formerly known as CTI Industries Corporation and changed its name to Yunhong CTI Ltd. in March 2020. Yunhong CTI Ltd. was founded in 1983 and is headquartered in Lake Barrington, Illinois.
Veru logo

Veru

NASDAQ:VERU
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, a selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection on oxygen support who are at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
West Pharmaceutical Services logo

West Pharmaceutical Services

NYSE:WST
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.